Infant Botulism, Israel, 2007–2021

Bar Goldberg, Dana Danino,Yoel Levinsky, Itzhak Levy, Rachel Straussberg, Halima Dabaja-Younis,Alex Guri, Yotam Almagor,Diana Tasher, Daniel Elad, Zina Baider,Shlomo Blum,Oded Scheuerman

Emerging Infectious Diseases(2023)

引用 3|浏览11
暂无评分
摘要
Infant botulism (IB) is an intestinal toxemia that manifests as descending paralysis, constipation, and, in some cases, respiratory failure. Laboratory-confirmed IB cases are rare, and recent data in Israel are lacking. We conducted a national multicenter retrospective study of laboratory-confirmed IB cases reported in Israel during 2007–2021. A total of 8 cases were reported during the study period. During 2019–2021, incidence may have increased because of a cluster of 5 cases. Infant median age for diagnosis was 6.5 months, older than previously reported (3 months). Most cases occurred during March–July. Honey consumption was reported in 1 case, and possible environmental risk factors (living nearby rural or construction areas, dust exposure, and having a father who works as a farmer) were reported in 6 cases. Although IB is rare, its incidence in Israel may have increased over recent years, and its epidemiology and risk factors differ from cases reported previously in Israel.
更多
查看译文
关键词
infant botulism,pediatrics,epidemiology,honey,botulism neurotoxin,Clostridium botulinum
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要